EC Dopearl Combination Tablets (YJ code: 1169100F1052, standard: 1 tablet) are manufactured by Ohara Pharmaceutical. This medication combines levodopa, a dopamine precursor, with benserazide hydrochloride, a peripheral decarboxylase inhibitor, to treat Parkinson’s disease and Parkinsonian syndrome by increasing dopamine levels in the brain.
EC Dopearl Combination Tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
